The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Indonesia has one of the fastest-growing pharmaceutical and healthcare sectors in ASEAN. The Indonesian government launched a comprehensive national health insurance scheme in 2014 to ensure that all Indonesians have access to healthcare. Almost all ...
View more details
Southeast Asia is a subregion of the Asian continent which comprises eleven countries, notably Brunei Darussalam, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, Timor Leste, and Vietnam ...
View more details
Indonesia is one of the ASEAN countries with the fastest-growing pharmaceuticals and healthcare sector. The Indonesian implemented a comprehensive public health insurance programme in 2014 to ensure that all Indonesians have access to healthcare. The ...
View more details
Southeast Asia is a subregion of the Asian continent which comprises eleven countries, notably Brunei Darussalam, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, Timor Leste, and Vietnam ...
View more details
A decade after Indonesia's government launched its comprehensive public health insurance programme, the Jaminan Kesehatan Nasional (JKN), the scheme has reached 90% of the population by end-2022. The progressive rollout of this programme has allowed ...
View more details
Indonesia's pharmaceuticals and healthcare sector is amongst the fastest growing in the ASEAN region. The Indonesian government introduced a comprehensive public health insurance programme in 2014 to deliver universal healthcare to Indonesians. The ...
View more details
The SEA region has had an admirable record in improving its record against infectious diseases over the nearly three decades from 1990 to 2019. The region’s rapid economic growth relative to the rest of the world has contributed to ...
View more details
Indonesia’s pharmaceuticals and healthcare sector is one of the fastest-growing in the ASEAN region. The Indonesian government has prioritised widening healthcare access and increasing the healthcare system’s capacity since 2014. However, ...
View more details